BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 17711928)

  • 21. Effects of androgen therapy on adipose tissue and metabolism in older men.
    Schroeder ET; Zheng L; Ong MD; Martinez C; Flores C; Stewart Y; Azen C; Sattler FR
    J Clin Endocrinol Metab; 2004 Oct; 89(10):4863-72. PubMed ID: 15472177
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of sex hormone levels and some metabolic factors in men with coronary atherosclerosis.
    Dunajska K; Milewicz A; Szymczak J; Jêdrzejuk D; Kuliczkowski W; Salomon P; Nowicki P
    Aging Male; 2004 Sep; 7(3):197-204. PubMed ID: 15669538
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Associations of endogenous sex hormones and sex hormone-binding globulin with lipid profiles in aged Japanese men and women.
    Yasui T; Uemura H; Irahara M; Arai M; Kojimahara N; Okabe R; Ishii Y; Tashiro S; Sato H
    Clin Chim Acta; 2008 Dec; 398(1-2):43-7. PubMed ID: 18755173
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Leptin and androgens in male obesity: evidence for leptin contribution to reduced androgen levels.
    Isidori AM; Caprio M; Strollo F; Moretti C; Frajese G; Isidori A; Fabbri A
    J Clin Endocrinol Metab; 1999 Oct; 84(10):3673-80. PubMed ID: 10523013
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oral anabolic steroid treatment, but not parenteral androgen treatment, decreases abdominal fat in obese, older men.
    Lovejoy JC; Bray GA; Greeson CS; Klemperer M; Morris J; Partington C; Tulley R
    Int J Obes Relat Metab Disord; 1995 Sep; 19(9):614-24. PubMed ID: 8574271
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Leptin and aging: correlation with endocrine changes in male and female healthy adult populations of different body weights.
    Isidori AM; Strollo F; Morè M; Caprio M; Aversa A; Moretti C; Frajese G; Riondino G; Fabbri A
    J Clin Endocrinol Metab; 2000 May; 85(5):1954-62. PubMed ID: 10843181
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The differences between aromatizable and non-aromatizable androgens in relation to body composition and metabolic syndrome risk factors in men.
    Pospíšilová H; Vaňková M; Hill M; Meloun M; Bendlová B; Dušková M; Stárka L
    J Steroid Biochem Mol Biol; 2012 Oct; 132(1-2):105-11. PubMed ID: 22421634
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relations of body fat and fat distribution to the serum lipid, apolipoprotein and insulin concentrations of Samoan men and women.
    Galanis DJ; McGarvey ST; Sobal J; Bausserman L; Levinson PD
    Int J Obes Relat Metab Disord; 1995 Oct; 19(10):731-8. PubMed ID: 8589767
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relationship of serum leptin levels with body composition and sex steroid and insulin levels in men and women.
    Thomas T; Burguera B; Melton LJ; Atkinson EJ; O'Fallon WM; Riggs BL; Khosla S
    Metabolism; 2000 Oct; 49(10):1278-84. PubMed ID: 11079816
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Glucose-to-insulin ratio rather than sex hormone-binding globulin and adiponectin levels is the best predictor of insulin resistance in nonobese women with polycystic ovary syndrome.
    Ducluzeau PH; Cousin P; Malvoisin E; Bornet H; Vidal H; Laville M; Pugeat M
    J Clin Endocrinol Metab; 2003 Aug; 88(8):3626-31. PubMed ID: 12915646
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of testosterone supplementation on whole body and regional fat mass and distribution in human immunodeficiency virus-infected men with abdominal obesity.
    Bhasin S; Parker RA; Sattler F; Haubrich R; Alston B; Umbleja T; Shikuma CM;
    J Clin Endocrinol Metab; 2007 Mar; 92(3):1049-57. PubMed ID: 17164307
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Insulin resistance, insulin response, and obesity as indicators of metabolic risk.
    Ferrannini E; Balkau B; Coppack SW; Dekker JM; Mari A; Nolan J; Walker M; Natali A; Beck-Nielsen H;
    J Clin Endocrinol Metab; 2007 Aug; 92(8):2885-92. PubMed ID: 17504904
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Androgens in relationship to cardiovascular risk factors in the menopausal transition.
    Mesch VR; Siseles NO; Maidana PN; Boero LE; Sayegh F; Prada M; Royer M; Schreier L; Benencia HJ; Berg GA
    Climacteric; 2008; 11(6):509-17. PubMed ID: 18991078
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High serum adiponectin is associated with low blood haemoglobin in elderly men: the Swedish MrOS study.
    Lewerin C; Johansson H; Lerner UH; Karlsson MK; Lorentzon M; Barrett-Connor E; Smith U; Ohlsson C; Mellström D
    J Intern Med; 2015 Jul; 278(1):68-76. PubMed ID: 25491722
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Levels of plasma steroid glucuronides in intact and castrated men with prostatic cancer.
    Bélanger A; Brochu M; Cliche J
    J Clin Endocrinol Metab; 1986 May; 62(5):812-5. PubMed ID: 2937801
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Altered metabolism of androgens in elderly men with benign prostatic hyperplasia.
    Ishimaru T; Pages L; Horton R
    J Clin Endocrinol Metab; 1977 Oct; 45(4):695-701. PubMed ID: 72074
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Testosterone therapy prevents gain in visceral adipose tissue and loss of skeletal muscle in nonobese aging men.
    Allan CA; Strauss BJ; Burger HG; Forbes EA; McLachlan RI
    J Clin Endocrinol Metab; 2008 Jan; 93(1):139-46. PubMed ID: 17940111
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Central-to-peripheral fat ratio, but not peripheral body fat, is related to insulin resistance and androgen markers in polycystic ovary syndrome.
    Godoy-Matos AF; Vaisman F; Pedrosa AP; Farias ML; Mendonça LM; Pinheiro MF
    Gynecol Endocrinol; 2009 Dec; 25(12):793-8. PubMed ID: 19905998
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Glucocorticoid-induced androgen inactivation by aldo-keto reductase 1C2 promotes adipogenesis in human preadipocytes.
    Veilleux A; Côté JA; Blouin K; Nadeau M; Pelletier M; Marceau P; Laberge PY; Luu-The V; Tchernof A
    Am J Physiol Endocrinol Metab; 2012 Apr; 302(8):E941-9. PubMed ID: 22275760
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Testosterone to dihydrotestosterone ratio as a new biomarker for an adverse metabolic phenotype in the polycystic ovary syndrome.
    Münzker J; Hofer D; Trummer C; Ulbing M; Harger A; Pieber T; Owen L; Keevil B; Brabant G; Lerchbaum E; Obermayer-Pietsch B
    J Clin Endocrinol Metab; 2015 Feb; 100(2):653-60. PubMed ID: 25387259
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.